ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/08/08 | 2,361 | 2,400 | 2,360 | 2,395 | +34 | +1.4% | 33,100 |
2023/08/07 | 2,333 | 2,361 | 2,325 | 2,361 | +32 | +1.4% | 37,600 |
2023/08/04 | 2,330 | 2,350 | 2,310 | 2,329 | -31 | -1.3% | 63,500 |
2023/08/03 | 2,375 | 2,377 | 2,350 | 2,360 | -14 | -0.6% | 90,300 |
2023/08/02 | 2,380 | 2,397 | 2,368 | 2,374 | -7 | -0.3% | 64,100 |
2023/08/01 | 2,349 | 2,381 | 2,339 | 2,381 | +54 | +2.3% | 53,700 |
2023/07/31 | 2,374 | 2,374 | 2,318 | 2,327 | +3 | +0.1% | 68,100 |
2023/07/28 | 2,312 | 2,333 | 2,305 | 2,324 | -19 | -0.8% | 110,100 |
2023/07/27 | 2,308 | 2,344 | 2,308 | 2,343 | +16 | +0.7% | 60,200 |
2023/07/26 | 2,324 | 2,331 | 2,310 | 2,327 | -13 | -0.6% | 63,800 |
2023/07/25 | 2,371 | 2,371 | 2,332 | 2,340 | -23 | -1% | 45,100 |
2023/07/24 | 2,349 | 2,364 | 2,340 | 2,363 | +34 | +1.5% | 38,500 |
2023/07/21 | 2,314 | 2,337 | 2,304 | 2,329 | ±0 | ±0% | 63,100 |
2023/07/20 | 2,350 | 2,355 | 2,325 | 2,329 | -17 | -0.7% | 30,700 |
2023/07/19 | 2,351 | 2,351 | 2,321 | 2,346 | +19 | +0.8% | 60,600 |
2023/07/18 | 2,300 | 2,329 | 2,300 | 2,327 | +27 | +1.2% | 27,700 |
2023/07/14 | 2,291 | 2,309 | 2,284 | 2,300 | +23 | +1% | 39,200 |
2023/07/13 | 2,264 | 2,285 | 2,263 | 2,277 | -4 | -0.2% | 36,300 |
2023/07/12 | 2,314 | 2,323 | 2,281 | 2,281 | -30 | -1.3% | 58,600 |
2023/07/11 | 2,346 | 2,358 | 2,305 | 2,311 | -35 | -1.5% | 52,800 |
2023/07/10 | 2,355 | 2,363 | 2,340 | 2,346 | -7 | -0.3% | 52,500 |
2023/07/07 | 2,390 | 2,390 | 2,349 | 2,353 | -25 | -1.1% | 58,500 |
2023/07/06 | 2,381 | 2,400 | 2,366 | 2,378 | -24 | -1% | 74,900 |
2023/07/05 | 2,400 | 2,424 | 2,400 | 2,402 | -25 | -1% | 39,400 |
2023/07/04 | 2,409 | 2,446 | 2,402 | 2,427 | -22 | -0.9% | 93,000 |
2023/07/03 | 2,456 | 2,481 | 2,430 | 2,449 | +6 | +0.2% | 36,800 |
2023/06/30 | 2,456 | 2,471 | 2,424 | 2,443 | -9 | -0.4% | 81,600 |
2023/06/29 | 2,487 | 2,510 | 2,442 | 2,452 | -29 | -1.2% | 57,800 |
2023/06/28 | 2,461 | 2,483 | 2,440 | 2,481 | +41 | +1.7% | 47,700 |
2023/06/27 | 2,427 | 2,454 | 2,409 | 2,440 | -26 | -1.1% | 65,100 |
2023/06/26 | 2,492 | 2,497 | 2,462 | 2,466 | -61 | -2.4% | 46,500 |
2023/06/23 | 2,550 | 2,550 | 2,510 | 2,527 | +3 | +0.1% | 97,400 |
2023/06/22 | 2,535 | 2,565 | 2,499 | 2,524 | -9 | -0.4% | 98,000 |
2023/06/21 | 2,537 | 2,553 | 2,526 | 2,533 | -4 | -0.2% | 105,300 |
2023/06/20 | 2,545 | 2,551 | 2,507 | 2,537 | -32 | -1.2% | 71,300 |
2023/06/19 | 2,555 | 2,569 | 2,537 | 2,569 | +14 | +0.5% | 51,000 |
2023/06/16 | 2,490 | 2,577 | 2,488 | 2,555 | +72 | +2.9% | 268,900 |
2023/06/15 | 2,518 | 2,518 | 2,474 | 2,483 | -52 | -2.1% | 104,000 |
2023/06/14 | 2,590 | 2,592 | 2,535 | 2,535 | -48 | -1.9% | 90,400 |
2023/06/13 | 2,558 | 2,600 | 2,558 | 2,583 | +37 | +1.5% | 117,700 |
2023/06/12 | 2,524 | 2,577 | 2,520 | 2,546 | +30 | +1.2% | 195,900 |
2023/06/09 | 2,498 | 2,533 | 2,483 | 2,516 | +51 | +2.1% | 158,300 |
2023/06/08 | 2,460 | 2,492 | 2,449 | 2,465 | +12 | +0.5% | 107,700 |
2023/06/07 | 2,449 | 2,485 | 2,444 | 2,453 | +36 | +1.5% | 118,200 |
2023/06/06 | 2,392 | 2,421 | 2,369 | 2,417 | +17 | +0.7% | 62,700 |
2023/06/05 | 2,445 | 2,450 | 2,393 | 2,400 | +12 | +0.5% | 88,600 |
2023/06/02 | 2,365 | 2,391 | 2,345 | 2,388 | +53 | +2.3% | 82,400 |
2023/06/01 | 2,342 | 2,362 | 2,333 | 2,335 | -4 | -0.2% | 83,900 |
2023/05/31 | 2,364 | 2,403 | 2,327 | 2,339 | -64 | -2.7% | 206,900 |
2023/05/30 | 2,430 | 2,442 | 2,389 | 2,403 | -48 | -2% | 79,800 |
501~
550
件表示中 / 3769件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 206,000円 | +3.1% | -6.5% | 2.33% | 9.56倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 274,000円 | +21.7% | +999.9% | 0.00% | 12.62倍 | 4.32倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 318,500円 | +5.1% | -7.0% | 2.51% | 20.91倍 | 0.86倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 154,600円 | -2.4% | -52.3% | 3.69% | 18.50倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 238,900円 | +4.1% | -3.1% | 2.43% | 20.75倍 | 1.81倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム